Apply for active substance renewal by the deadlines to keep products on the GB market. Under the GB Biocidal Products Regulation (GB BPR), active substance approvals will expire unless a renewal application is submitted at least 550 days before their expiry date. The 550-day deadlines are coming up for the following active substance/product type combinations under GB BPR: - Abamectin as a mixture of avermectin B1a (EINECS 265-610-3) and avermectin B1b (EINECS 265-611-9) (CAS 71751-41-2 EC n/a) in product type 18
27 December 2021
- 4,5-Dichloro-2-octylisothiazol-3(2H)-one (4,5-Dichloro-2-octyl-2H-isothiazol-3-one (DCOIT)) (CAS 64359-81-5 EC 264-843-8) in product type 8
27 December 2021
- (2E)-1-[(6-chloropyridin-3-yl) methyl]-N-nitroimidazolidin-2- imine (Imidacloprid) (CAS 138261-41-3 EC 428-040-8) in product type 18
27 December 2021
- Reaction mass of (R)-α-cyano- 3-phenoxybenzyl (1S,3S)-3-[(Z)-2- chloro-3,3,3-trifluoropropenyl]-2,2-dimethylcyclopropanecarboxylate and (S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-[(Z)-2-chloro-3,3,3- trifluoropropenyl]-2,2- dimethylcyclopropanecarboxylate (1:1) (lambda-cyhalothrin) (CAS 91465-08-6 EC 415-130-7) in product type 18
29 March 2022
- Bacillus thuringiensis subsp. israelensis Serotype H14, Strain AM65-52 (CAS n/a EC n/a) in product type 18
29 March 2022
- (S)-α-cyano-3-phenoxybenzyl (1R,3R)-3-(2,2-dibromovinyl)-2,2- dimethylcyclopropane carboxylate (Deltamethrin) (CAS 52918-63-5 EC 258-256-6) in product type 18
29 March 2022
- (±)-5-amino-1-(2,6- dichloro-α,α,α,- trifluoro-p-tolyl)-4- trifluoromethylsulfinylpyrazole-3-carbonitrile (1:1) (Fipronil) (CAS 120068-37-3 EC 424-610-5) in product type 18
29 March 2022
- Hydrogen cyanide (CAS 74-90-8 EC 200-821-6) in product types 8, 14 and 18
30 March 2023
- cis-Tricos-9-ene, (Z)-Tricos-9-ene (Muscalure) (CAS 27519-02-4 EC 248-505-7) in product type 19
30 March 2023 Any person, company or taskforce/consortium can support an active substance/product type combination for renewal – it doesn't have to be the original supporter. If a renewal application is not submitted for the above active substance/product type combinations under GB BPR, the approvals will expire. This means the active substances can no longer be used in biocidal products of the relevant product types in Great Britain. Biocidal products must be phased off the GB market. The active substance/product type combinations listed below are due to expire under the GB Biocidal Products Regulation (GB BPR) on the following date: - N,N′-methylenebismorpholine (MBM) (CAS 5625-90-1 EC 227-062-3) in product types 6 and 13
31 March 2022 Once the approvals expire, the active substance can no longer be used in biocidal products of the relevant product types in Great Britain. If you hold an affected GB BPR product authorisation or Control of Pesticides Regulations (COPR) product approval, we will contact you about cancelling or revoking your authorisation or approval. You will have an opportunity to submit comments or additional information and we will take account of these when finalising our decision. If you are aware of any disproportionate negative effects that are likely to arise from the expiry of any of the active substance/product type combinations listed above, please contact us. Make sure you are receiving important information about your product authorisations and approvals. Businesses that hold product authorisations and approvals in Great Britain and Northern Ireland under the GB and EU Biocidal Products Regulations (GB BPR and EU BPR) or the Control of Pesticides Regulations (COPR) should make sure HSE has the right contact details. If the details we hold are out of date, you may not receive important information about your product authorisation or approval. Update your details by emailing us at biocidesapplications@hse.gov.uk. We would be grateful for your feedback on some changes we have made.
We have updated the introductory guidance and the lists of products, active substances and suppliers.
If you can spare 10 minutes to help us, please complete the survey (on the SurveyMonkey website). Go to survey | 
No comments:
Post a Comment